Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Antiinfective agents claimed by GlaxoSmithKline

Jan. 13, 2005

A valopicitabine plus pegylated interferon regimen shows promise in hepatitis C

Jan. 13, 2005

Traficet-EN studied in phase II for IBD

Jan. 13, 2005

Biolex seeks approvals for phase I trials of BLX-883

Jan. 13, 2005

Scientists at Enanta report novel agents for hepatitis C infections

Jan. 12, 2005

HCV NS3-NS4A protease inhibitor and INF-alpha synergistically inhibit HCV replication in vitro

Jan. 12, 2005

IND submission for HCV-796

Jan. 12, 2005

Approvable letter for Sanvar IR for esophageal variceal bleeding

Jan. 10, 2005

Bristol-Myers Squibb patent covers new agents for hepatitis C infection

Jan. 10, 2005

IND filing for clinical testing of Probactrix for pouchitis

Jan. 10, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.